Trice Medical says it reeled in the 1st tranche of a nearly $12 million Series B round and named ex-Embrella Cardiovascular Jeffrey O'Donnell Sr. as chairman & CEO.
Trice Medical said it raised the 1st tranche of an $11.6 million Series B round and named medtech veteran Jeffrey O'Donnell Sr. as its new CEO.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1x2dKYL
Cap comentari:
Publica un comentari a l'entrada